X

Infection/Disease

Expanding our ability to test, test, test

At the moment, people who are suspected of having Covid 19 undergo a swab PCR test which looks for genetic…

Scientists closer to treatment for myotonic dystrophy

Scientists at the University of Nottingham have taken a step closer towards developing a treatment for the long-term genetic disorder,…

How lockdown impacts those with bone, joint and muscle pain

How does lockdown impact those people with bone, joint and muscle pain? University of East Anglia researchers are launching a…

Nanoparticles effective in treatment of severe inflammatory processes

Researchers from the Galien Institute at Paris-Saclay University/ CNRS have developed nanoparticles that are effective in the treatment of severe…

WHO warns immunization coverage at risk

Shutting down immunization services in the COVID-19 pandemic risks triggering a resurgence of diseases that can be prevented with safe…

Covid-19: People aged 60-69 at increased risk

The 7.3 million people in the UK aged between 60 and 69 are at increased risk of severe illness and…

Covid-19: AI auto-scans lung X-rays

Coronavirus can be identified automatically from sick patients' lung X-rays using artificial intelligence (AI) developed at Brunel University London. The…

Covid-19: WHO brief on Immunity passports

A Scientific Brief on "Immunity passports" in the context of COVID-19 has been published by the World Health Organisation. WHO…

A happy gut is an anti-inflammatory gut

Study discovers the link between an the anti-inflammatory gut and seratonin. The scientific journal, Cell Metabolism publishes this April, the…

COVID-19 vaccine begins human trial stage

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will…

This website uses cookies.